Literature DB >> 1448403

Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease.

D King1, J R Playfer, N B Roberts.   

Abstract

Concentrations of the naturally occurring antioxidant vitamins A, C and E were measured in 27 patients with Parkinson's disease and 16 age-matched control subjects, from a similarly disabled patient group. There was no significant difference in the serum concentrations of vitamins A and E in the two groups. Vitamin C was significantly higher (P < 0.05) in the Parkinson's disease group, however, the mean leucocyte vitamin C concentration in the control group was low (101 nmol/10(8) WBCS) compared to established data in healthy young individuals (119-301 nmol/10(8) WBCS). There was no correlation between the severity or duration of Parkinson's disease and concentrations of vitamins A, C and E. There is therefore no evidence from this study that a deficiency of these antioxidants contributes to the onset or progress of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448403      PMCID: PMC2399571          DOI: 10.1136/pgmj.68.802.634

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  The determination of ascorbic acid in white blood cells. A comparison of W.B.C. ascorbic acid and phenolic acid excretion in elderly patients.

Authors:  K W DENSON; E F BOWERS
Journal:  Clin Sci       Date:  1961-10       Impact factor: 6.124

2.  Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease.

Authors:  J W Langston; P Ballard
Journal:  Can J Neurol Sci       Date:  1984-02       Impact factor: 2.104

3.  Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography.

Authors:  G L Catignani; J G Bieri
Journal:  Clin Chem       Date:  1983-04       Impact factor: 8.327

Review 4.  Antioxidant therapy in Parkinson's disease.

Authors:  J D Grimes; M N Hassan; J Thakar
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

5.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

Review 6.  Vitamin E--its role in neurological function.

Authors:  D P Muller
Journal:  Postgrad Med J       Date:  1986-02       Impact factor: 2.401

7.  Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.

Authors:  T L Perry; V W Yong; R M Clavier; K Jones; J M Wright; J G Foulks; R A Wall
Journal:  Neurosci Lett       Date:  1985-09-30       Impact factor: 3.046

8.  Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

Authors:  G Martinovits; E Melamed; O Cohen; J Rosenthal; A Uzzan
Journal:  Neurosci Lett       Date:  1986-08-29       Impact factor: 3.046

9.  The spectrum of neurologic disorder from vitamin E deficiency.

Authors:  S Satya-Murti; L Howard; G Krohel; B Wolf
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

10.  Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  T L Perry; V W Yong; S Hansen; K Jones; C Bergeron; J G Foulks; J M Wright
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

View more
  6 in total

Review 1.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

2.  Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.

Authors:  J A Molina; F de Bustos; F J Jiménez-Jiménez; J Benito-León; M Ortí-Pareja; T Gasalla; A Tallón-Barranco; J A Navarro; J Arenas; R Enríquez-de-Salamanca
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Toxicity of dopamine and dopaminochrome on cultured cells.

Authors:  L Galzigna; L Zanatta; N Esposito
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

Review 4.  Preventive and therapeutic potential of ascorbic acid in neurodegenerative diseases.

Authors:  Morgana Moretti; Daiane Bittencourt Fraga; Ana Lúcia S Rodrigues
Journal:  CNS Neurosci Ther       Date:  2017-10-04       Impact factor: 5.243

5.  Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.

Authors:  Haijie Liu; Yan Zhang; Haihua Zhang; Longcai Wang; Tao Wang; Zhifa Han; Liyong Wu; Guiyou Liu
Journal:  J Transl Med       Date:  2021-05-24       Impact factor: 5.531

6.  Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease.

Authors:  Carmen Costas; Lilian R F Faro
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.